Patents by Inventor Anne Y. Lai

Anne Y. Lai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRESERVATION OF IMMUNE RESPONSE DURING CHEMOTHERAPY REGIMENS
    Publication number: 20230302001
    Abstract: The addition of a selective, fast-acting, short half-life CDK 4/6 inhibitor in a very specific dosage regimen to the combination of chemotherapy with a checkpoint inhibitor provides superior results in the treatment of a tumor or cancer. The unexpected discovery is that the short pulsatile specifically-timed administration of a selective, fast-acting, short half-life CDK 4/6 inhibitor during administration of the chemotherapy portion of the triple combination therapy has a profound effect on the immune cells in the cancer microenvironment.
    Type: Application
    Filed: December 1, 2022
    Publication date: September 28, 2023
    Applicant: G1 Therapeutics, Inc.
    Inventors: Jessica A. Sorrentino, Anne Y. Lai, Jay C. Strum, Patrick Joseph Roberts
  • Preservation of immune response during chemotherapy regimens
    Patent number: 11529352
    Abstract: The addition of a selective, fast-acting, short half-life CDK 4/6 inhibitor in a very specific dosage regimen to the combination of chemotherapy with a checkpoint inhibitor provides superior results in the treatment of a tumor or cancer. The unexpected discovery is that the short pulsatile specifically-timed administration of a selective, fast-acting, short half-life CDK 4/6 inhibitor during administration of the chemotherapy portion of the triple combination therapy has a profound effect on the immune cells in the cancer microenvironment.
    Type: Grant
    Filed: June 5, 2019
    Date of Patent: December 20, 2022
    Assignee: G1 Therapeutics, Inc.
    Inventors: Jessica A. Sorrentino, Anne Y. Lai, Jay C. Strum, Patrick Joseph Roberts